|
1
|
Thompson BT, Chambers RC and Liu KD: Acute
respiratory distress syndrome. N Engl J Med. 377:562–572. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fan E, Brodie D and Slutsky AS: Acute
respiratory distress syndrome: Advances in diagnosis and treatment.
JAMA. 319:698–710. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lau AN, Goodwin M, Kim CF and Weiss DJ:
Stem cells and regenerative medicine in lung biology and diseases.
Mol Ther. 20:1116–1130. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weiss DJ: Stem cells, cell therapies, and
bioengineering in lung biology and diseases. Comprehensive review
of the recent literature 2010–2012. Ann Am Thorac Soc. 10:S45–S97.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee JW, Gupta N, Serikov V and Matthay MA:
Potential application of mesenchymal stem cells in acute lung
injury. Expert Opin Biol Ther. 9:1259–1270. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu F, Hu Y, Zhou J and Wang X: Mesenchymal
stem cells in acute lung injury: Are they ready for translational
medicine? J Cell Mol Med. 17:927–935. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bustos ML, Huleihel L, Kapetanaki MG,
Lino-Cardenas CL, Mroz L, Ellis BM, McVerry BJ, Richards TJ,
Kaminski N, Cerdenes N, et al: Aging mesenchymal stem cells fail to
protect because of impaired migration and antiinflammatory
response. Am J Respir Crit Care Med. 189:787–798. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Laffey JG and Matthay MA: Fifty years of
research in ARDS. Cell-based therapy for acute respiratory distress
syndrome. Biology and potential therapeutic value. Am J Respir Crit
Care Med. 196:266–273. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang SR, Park JR and Kang KS: Reactive
oxygen species in mesenchymal stem cell aging: Implication to lung
diseases. Oxid Med Cell Longev. 2015:4862632015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Espinoza F, Aliaga F and Crawford PL:
Overview and perspectives of mesenchymal stem cell therapy in
intensive care medicine. Rev Med Chil. 144:222–231. 2016.In
Spanish. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li L, Dong L, Hui J, Gao F, Wang Q, Yang
L, Zhang J and Yan J: Under-expression of LATS1 promotes the
differentiation, proliferation and migration of mesenchymal stem
cells by inhibition the Hippo signaling pathway in vitro. Zhonghua
Wei Zhong Bing Ji Jiu Yi Xue. 29:731–737. 2017.In Chinese.
PubMed/NCBI
|
|
12
|
National Research Council (US) Institute
for Laboratory Animal Research: Guide for the Care and Use of
Laboratory Animals. National Academies Press; Washington, DC:
1996
|
|
13
|
Smith KM, Mrozek JD, Simonton SC, Bing DR,
Meyers PA, Connett JE and Mammel MC: Prolonged partial liquid
ventilation using conventional and high-frequency ventilatory
techniques: Gas exchange and lung pathology in an animal model of
respiratory distress syndrome. Crit Care Med. 25:1888–1897. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ashcroft T, Simpson JM and Timbrell V:
Simple method of estimating severity of pulmonary fibrosis on a
numerical scale. J Clin Pathol. 41:467–470. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He H, Liu L, Chen Q, Liu A, Cai S, Yang Y,
Lu X and Qiu H: Mesenchymal stem cells overexpressing
angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced
lung injury. Cell Transplant. 24:1699–1715. 2015. View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Dong L, He HL, Lu XM, Yang Y and Qiu HB:
Modulation of FLT3 signaling targets conventional dendritic cells
to attenuate acute lung injury. APMIS. 120:808–818. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun Y, Liu JG, Zheng YC, Xiao CL, Wan B,
Guo L, Wang XG and Bo W: Research on rat's pulmonary acute injury
induced by lunar soil simulant. J Chin Med Assoc. 81:133–140. 2018.
View Article : Google Scholar
|
|
19
|
Tam A, Wadsworth S, Dorscheid D, Man SF
and Sin DD: The airway epithelium: More than just a structural
barrier. Ther Adv Respir Dis. 5:255–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Standiford TJ and Ward PA: Therapeutic
targeting of acute lung injury and acute respiratory distress
syndrome. Transl Res. 167:183–191. 2016. View Article : Google Scholar
|
|
21
|
Moodley Y, Sturm M, Shaw K, Shimbori C,
Tan DB, Kolb M and Graham R: Human mesenchymal stem cells attenuate
early damage in a ventilated pig model of acute lung injury. Stem
Cell Res. 17:25–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McIntyre LA, Moher D, Fergusson DA,
Sullivan KJ, Mei SH, Lalu M, Marshall J, Mcleod M, Griffin G,
Grimshaw J, et al: Efficacy of mesenchymal stromal cell therapy for
acute lung injury in preclinical animal models: A systematic
review. PLoS One. 11:e01471702016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hayes M, Curley G, Ansari B and Laffey JG:
Clinical review: Stem cell therapies for acute lung injury/acute
respiratory distress syndrome-hope or hype? Crit Care. 16:2052012.
View Article : Google Scholar
|
|
24
|
Sardo FL, Strano S and Blandino G: The
Hippo kinase pathway: A master regulator of proliferation,
development and differentiation. Atlas Genet Cytogenet Oncol
Haematol. 19:65–77. 2015.
|
|
25
|
Johnson R and Halder G: The two faces of
Hippo: Targeting the Hippo pathway for regenerative medicine and
cancer treatment. Nat Rev Drug Discov. 13:63–79. 2014. View Article : Google Scholar :
|
|
26
|
Zhang Q, Meng F, Chen S, Plouffe SW, Wu S,
Liu S, Li X, Zhou R, Wang J, Zhao B, et al: Hippo signalling
governs cytosolic nucleic acid sensing through YAP/TAZ-mediated
TBK1 blockade. Nat Cell Biol. 19:362–374. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao B, Tumaneng K and Guan KL: The Hippo
pathway in organ size control, tissue regeneration and stem cell
self-renewal. Nat Cell Biol. 13:877–883. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu J, Woods CR, Mora AL, Joodi R, Brigham
KL, Iyer S and Rojas M: Prevention of endotoxin-induced systemic
response by bone marrow-derived mesenchymal stem cells in mice. Am
J Physiol Lung Cell Mol Physiol. 293:L131–L141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
De Becker A, Van Hummelen P, Bakkus M,
Vande Broek I, De Wever J, De Waele M and Van Riet I: Migration of
culture-expanded human mesenchymal stem cells through bone marrow
endothelium is regulated by matrix metalloproteinase-2 and tissue
inhibitor of metalloproteinase-3. Haematologica. 92:440–449. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schioppa T, Uranchimeg B, Saccani A,
Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni
M, Vago L, et al: Regulation of the chemokine receptor CXCR4 by
hypoxia. J Exp Med. 198:1391–1402. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
An Y, Kang Q, Zhao Y, Hu X and Li N: Lats2
modulates adipocyte proliferation and differentiation via hippo
signalling. PLoS One. 8:e720422013. View Article : Google Scholar
|
|
32
|
Tang Y, Feinberg T, Keller ET, Li XY and
Weiss SJ: Snail/Slug binding interactions with YAP/TAZ control
skeletal stem cell self-renewal and differentiation. Nat Cell Biol.
18:917–929. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen Z, Luo Q, Lin C, Kuang D and Song G:
Simulated microgravity inhibits osteogenic differentiation of
mesenchymal stem cells via depolymerizing F-actin to impede TAZ
nuclear translocation. Sci Rep. 6:303222016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He Q, Huang HY, Zhang YY, Li X and Qian
SW: TAZ is downregulated by dexamethasone during the
differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res
Commun. 419:573–577. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Deel MD, Li JJ, Crose LE and Linardic CM:
A Review: Molecular aberrations within Hippo signaling in bone and
soft-tissue sarcomas. Front Oncol. 5:1902015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin X, Barravecchia M, Kothari P, Young JL
and Dean DA: β1-Na(+), K(+)-ATPase gene therapy upregulates tight
junctions to rescue lipopolysaccharide-induced acute lung injury.
Gene Ther. 23:489–499. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pati S, Gerber MH, Menge TD, Wataha KA,
Zhao Y, Baumgartner JA, Zhao J, Letourneau PA, Huby MP, Baer LA, et
al: Bone marrow derived mesenchymal stem cells inhibit inflammation
and preserve vascular endothelial integrity in the lungs after
hemorrhagic shock. PLoS One. 6:e251712011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Voiriot G, Razazi K, Amsellem V, Tran Van
Nhieu J, Abid S, Adnot S, Mekontso Dessap A and Maitre B:
Interleukin-6 displays lung anti-inflammatory properties and exerts
protective hemodynamic effects in a double-hit murine acute lung
injury. Respir Res. 18:642017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu H, Xiong Y, Xia Y, Zhang R, Tian D,
Wang T, Dai J, Wang L, Yao H, Jiang H, et al: Therapeutic effects
of human umbilical cord-derived mesenchymal stem cells in acute
lung injury mice. Sci Rep. 7:398892017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nicoletti F, Mancuso G, Cusumano V, Di
Marco R, Zaccone P, Bendtzen K and Teti G: Prevention of
endotoxin-induced lethality in neonatal mice by interleukin-13. Eur
J Immunol. 27:1580–1583. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qi D, Wang D, Zhang C, Tang X, He J, Zhao
Y, Deng W and Deng X: Vaspin protects against LPSinduced ARDS by
inhibiting inflammation, apoptosis and reactive oxygen species
generation in pulmonary endothelial cells via the Akt/GSK3β
pathway. Int J Mol Med. 40:1803–1817. 2017.PubMed/NCBI
|
|
42
|
Kao KC, Hu HC, Chang CH, Hung CY, Chiu LC,
Li SH, Lin SW, Chuang LP, Wang CW, Li LF, et al: Diffuse alveolar
damage associated mortality in selected acute respiratory distress
syndrome patients with open lung biopsy. Crit Care. 19:2282015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Blondonnet R, Constantin JM, Sapin V and
Jabaudon M: A pathophysiologic approach to biomarkers in acute
respiratory distress syndrome. Dis Markers. 2016:35013732016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wilcox ME and Herridge MS: Lung function
and quality of life in survivors of the acute respiratory distress
syndrome (ARDS). Presse Med. 40:e595–603. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang K, Wu XM, Wang XY, Kang XW, Xiao JL,
Li ZG and Lu P: The effect of marrow mesenchymal stem cell
transplantation on pulmonary fibrosis in rats. Zhonghua Jie He He
Hu Xi Za Zhi. 35:659–664. 2012.In Chinese. PubMed/NCBI
|
|
46
|
Fagone P, Mangano K, Mammana S, Pesce A,
Pesce A, Caltabiano R, Giorlandino A, Portale TR, Cavalli E,
Lombardo GA, et al: Identification of novel targets for the
diagnosis and treatment of liver fibrosis. Int J Mol Med.
36:747–752. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Devaney J, Horie S, Masterson C, Elliman
S, Barry F, O'Brien T, Curley GF, O'Toole D and Laffey JG: Human
mesenchymal stromal cells decrease the severity of acute lung
injury induced by E. coli in the rat. Thorax. 70:625–635. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shen Q, Chen B, Xiao Z, Zhao L, Xu X, Wan
X, Jin M, Dai J and Dai H: Paracrine factors from mesenchymal stem
cells attenuate epithelial injury and lung fibrosis. Mol Med Rep.
11:2831–2837. 2015. View Article : Google Scholar
|
|
49
|
Fagone P, Mangano K, Pesce A, Portale TR,
Puleo S and Nicoletti F: Emerging therapeutic targets for the
treatment of hepatic fibrosis. Drug Discov Today. 21:369–375. 2016.
View Article : Google Scholar
|
|
50
|
Shaver CM and Bastarache JA: Clinical and
biological heterogeneity in acute respiratory distress syndrome:
Direct versus indirect lung injury. Clin Chest Med. 35:639–653.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu L, Chen L, Jiang C, Guo J, Xie Y, Kang
L and Cheng Z: Berberine inhibits the LPS-induced proliferation and
inflammatory response of stromal cells of adenomyosis tissues
mediated by the LPS/TLR4 signaling pathway. Exp Ther Med.
14:6125–6130. 2017.PubMed/NCBI
|
